Cordis Gets New Stent Patent, Sues Abbott
In a move that could impede Abbott Laboratories' efforts to become the third company selling drug-eluting coronary stents in the United States, a Johnson & Johnson subsidiary has filed a lawsuit...To view the full article, register now.
Already a subscriber? Click here to view full article